DJ Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ shed 1.41% to $56.84 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 2.95% to 5,872.16 and Dow Jones Industrial Average falling 2.58% to 42,326.87.
The stock's fall snapped a two-day winning streak.
Bristol Myers Squibb Co. closed $4.24 below its 52-week high ($61.08), which the company achieved on November 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.13% to $144.75, Pfizer Inc. $(PFE)$ fell 2.04% to $25.89, and Abbott Laboratories $(ABT)$ fell 1.20% to $111.93.
Trading volume (13.6 M) eclipsed its 50-day average volume of 10.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 18, 2024 16:41 ET (21:41 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments